CaleoBio focuses on patient-first technologies to overcome the persistent limitations of conventional preclinical models. Our proprietary Organ-Dish platform is a self-organizing, multicellular system that replicates patient-specific tissue architecture and disease phenotypes relevant to multiple therapeutic areas. It supports mechanistic studies, drug screening, toxicology, and preclinical validation with greater human relevance. By combining biological complexity with computational imaging, we’re building a scalable framework to understand disease progression and therapeutic response.
We’re actively seeking collaborators and partners to advance more predictive, human-relevant models.
Company Details
- Address
- Washington, Washington,district Of Columbia 20009,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Rise Therapeutics.
- HQ
- Washington, District of Columbia
Caleo Biotechnologies Questions
Caleo Biotechnologies's website is http://www.caleobiotechnologies.com
Caleo Biotechnologies's LinkedIn profile is https://www.linkedin.com/company/caleo-biotechnologies
Caleo Biotechnologies's industry is
Biotechnology Research
Caleo Biotechnologies's top competitors are
Anderson Painting,
Oria,
Eyelevel.ai,
64x Bio,
Marvin Labs,
Blackbird Laboratories,
Coaptech,
Pvr (People. Value. Research),
Summit Exercises And Training,
Orthogonal.
Caleo Biotechnologies's categories are Biotechnology Research
